GENE ONLINE|News &
Opinion
Blog

Phase 1 Trial
Trials & Approvals Immunotherapy
Kura Oncology Boasts Immunotherapy Preliminary Trial Data Success
2022-10-26
Regulatory Gene Editing
Verve Cleared to Test Gene Editing Drug for Heart Disease in Humans
2022-05-12
COVID-19 Antibody Therapy
Celltrion Announces Positive Phase 1 Results for COVID-19 Antibody Therapy
2020-11-12
COVID-19 Vaccine
COVID-19: CureVac Announces Promising Phase 1 Results with Lower Vaccine Dosage Than Competitors
2020-11-03
R&D CRISPR
CRISPR Therapeutics’ CAR-T Cell Therapy Registers Mixed Results in Cancer Trial
2020-10-23
Trials & Approvals CRISPR
Intellia Trials CRISPR Drug as Permanent Cure to Fatal Hereditary Disease
2020-10-21
COVID-19
COVID-19: AstraZeneca and University of Oxford’s Vaccine Candidate Shows Promise in Early Human Trials
2020-07-20
COVID-19
COVID-19: Medicago Begins Phase I Trials for Plant-Based VLP Vaccine
2020-07-19
Legend Biotech Closes Initial Public Offering Raising Big Money
2020-06-10
R&D
ASCO 2020: Celyad’s Off the Shelf CAR-T Cell Therapy Shows Promise against Colorectal Cancer
2020-06-07
COVID-19
COVID-19: Moderna Registers Positive Phase 1 Results for mRNA Vaccine
2020-05-18
Asia-Pacific Alpha Helices
Eisai Obtains Novel Anti-Cancer Molecules via PRISM BioLab Contract
2020-04-13
R&D
Meru Reports Proof of Concept for Its Bispecific Antibody in NRG1 Fusion Cancers
2019-10-29
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top